John Libbey Eurotext

European Journal of Dermatology


Prognostic role of platelet to lymphocyte and lymphocyte to monocyte ratios in advanced melanoma treated with anti-programmed death-1 Volume 28, issue 5, September-October 2018


  • Figure 1
Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan

Immune-based prognostic factors, including the neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and lymphocyte to monocyte ratio (LMR), may be associated with the immune response in cancer [1, 2]. Recent studies have reported a relationship between the NLR and outcomes in melanoma [3-6]. Similarly, we previously reported that a high NLR was associated with poor overall survival (OS) in melanoma patients treated with anti-programmed death-1 (PD-1) therapy [7]. However, there [...]